VIGONVITA-B 02630Hong Kong Stock Exchange

80.8000.25%( -0.200 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
VIGONVITA-B (02630) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
Vigonvita Life Sciences Co., Ltd.
Market
HKEX Main Board
Listing Date
2025-11-06
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
CNE1000076N3

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)119.72M91/112
Net Profit (Last FY)-417.14M104/125
ROE (Last FY)-79.72%102/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
田广辉 Executive Director
胡天文 Executive Director
刘浩轩 Non-Executive Director
鞠佃文 Independent Non-Executive Director
曹新文 Independent Non-Executive Director
徐宏喜 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-06-30.

About this page

This page shows VIGONVITA-B (02630) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.